D vitamin and immunity;D vitamin a imunita

Vnitrni Lekarstvi

Volumn 58, Issue 5, 2012, Pages 405-410

  Šterzl, Ivan ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

Adaptive immunity; Autoimmunity; Infections; Innate immunity; Vitamin D

Indexed keywords

COLECALCIFEROL;

ADAPTIVE IMMUNITY; ANTIMICROBIAL ACTIVITY; ARTICLE; AUTOIMMUNITY; IMMUNOPATHOLOGY; INFECTION; INNATE IMMUNITY;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; CHOLECALCIFEROL; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE;

EID: 84862983933     PISSN: 0042773X     EISSN: 18017592     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Šterzl I. Přehledná imunoendokrinologie. Praha: Maxdorf 2006.
2. 3 in Control of Immune Response. In: Geenen V, Chrousos G (eds). Immunoendocrinology in Health and Disease. New York: Marcel Dekker 2006.
3. Adams JS, Ren S, Liu PT et al. Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 2009; 182: 4289-4295.
4. 3-1α-hydroxylase in human monocytes. J Bone Miner Res 2006; 21: 37-47.
5. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 2010; 39: 365-379.
6. Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 2004; 229: 1136-1142. (Pubitemid 39602256)
7. 3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004; 173: 2909-2912.
8. 3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J Immunol 2008; 181: 8504-8512.
9. 3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006; 36: 361-370.
10. Albert PJ, Proal AD, Marshall TG. Vitamin D: the alternative hypothesis. Autoimmun Rev 2009; 8: 639-644.
11. Hewison M, Freeman L, Hughes SV et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003; 170: 5382-5390. (Pubitemid 36617823)
12. 3 regulates c-myc mRNA levels in tonsillar T lymphocytes. Immunology 1991; 74: 589-593.
13. Mahon BD, Wittke A, Weaver V et al. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 2003; 89: 922-932.
14. 3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol 2004; 34: 1068-1076.
15. 3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 2000; 49: 1301-1307.
16. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006; 18: 349-356.
17. Barrat FJ, Cua DJ, Boonstra A et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195: 603-616. (Pubitemid 34461505)
18. 3 abrogates regulatory function. J Clin Invest 2009; 119: 387-398.
19. Meehan TF, DeLuca HF. CD8(+) T cells are not necessary for 1α,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Proc Natl Acad Sci USA 2002; 99: 5557-5560. (Pubitemid 34411587)
20. 3 to "program" T cell attraction to the epidermal chemokine CCL27. Nat Immunol 2007; 8: 285-293.
21. 3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984; 74: 657-661.
22. Amson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007; 66: 1137-1142. (Pubitemid 47309727)
23. Linker-Israeli M, Elstner E, Klinenberg JR et al. Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol 2001; 99: 82-93.
24. Ramagopalan SV, Maugeri NJ, Handunnetthi L et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009; 5: e1000369.
25. Munger KL, Levin LI, Hollis BW et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-2838. (Pubitemid 44969183)
26. Andjelkovic Z, Vojinovic J, Pejnovic N et al. Disease modifying and immunomodulatory effects of high dose 1α (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 1999; 17: 453-456. (Pubitemid 29343630)
27. Hyppönen E, Läärä E, Reunanen A et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358: 1500-1503. (Pubitemid 33055701)
28. Blaney GP, Albert PJ, Proal AD. Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Ann N Y Acad Sci 2009; 1173: 384-390.